RxDoctor Payments Data

Stephen Reintjes, MD

Neurological Surgery · North Kansas City, MONPI 1356630735

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $32,099 of the $48,568 with a category attached, or 66.1%. 14 manufacturers reported payments, led by Kuros Biosciences USA, Inc at 43.6% of the total. 2025 is the largest year on record at $37,053, more than ten times the $653 reported in 2019. Among neurological surgery clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$48,568in general payments, 2019–2025

Across 89 payments — averaging $545.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kuros Biosciences USA, Inc$21K
  • Medtronic$12K
  • Globus Medical$11K
  • Alphatec Spine, Inc$4K
  • Stryker$130
  • Boston Scientific$125
  • plus $341 from 8 others

What the payments were for

  • Consulting fees$32,09966%
  • Travel & lodging$13,05927%
  • Food & beverage$3,3937%
  • Entertainment$160%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$48,568 in reported general payments places this provider in the 90th percentile of 172 neurological surgery providers in Missouri.

See all neurological surgery providers in Missouri

Medicare billing

Part B allowed, 2024
$621,092
Medicare patients
621
Services billed
1,791

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ForteoTeriparatide19$80,223
TymlosAbaloparatide30$79,746
Teriparatide15$31,731
Methocarbamol537$4,529
Gabapentin316$4,006
Pregabalin185$2,835
Oxycodone Hcl342$2,117
Meloxicam494$1,080
Lidocaine16$951
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$509
Tizanidine Hcl39$482
Tramadol Hcl85$288
Baclofen12$236
Methylprednisolone28$213
Cyclobenzaprine Hcl22$173

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Radius Health, Inc.Tymlos$21$79,74630 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 172 neurological surgery providers in Missouri.

Other neurological surgery in North Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →